Key result
A proof-of-concept 3D-printed hydrogel aortic valve displayed a low transvalvular pressure gradient of 14–24 mmHg and endured a cyclic pressure of ~80 mmHg for at least 180,000 cycles.
Why the study?
Bioprosthetic cardiac valves treat valvular heart diseases such as stenosis and regurgitation, but often suffer from issues including mechanical mismatch, biocompatibility, thrombus, and degradation.
A novel 3D-printed hydrogel bioprosthetic valve demonstrates favorable mechanical properties, hemocompatibility, and durability in vitro, offering a potential future alternative for heart valve replacement.
Answers are grounded in this paper and cite their sources.
Should not change valve selection in practice; leaves open hydrogel valves as a future biomaterial option pending in vivo validation.
Bioprosthetic cardiac valves are efficient replacements to clinically treat the valvular heart diseases including stenosis and regurgitation, while these often suffer from the issues of mechanical mismatch, biocompatibility, thrombus, degradation, etc. Here, we report a big step toward the biomechanically compatible hydrogel heart valves by the reversible addition–fragmentation chain transfer polymerization compatible three-dimensional (RAFT-3D) printing tough hydrogels. The biocompatible hydrogel valves have favorable mechanical properties matching with native valves and long-term stability and durability owing to the wide and robust hydrogen-bonding networks, on which the heparin-like polymer with −SO3– is readily grafted through RAFT polymerization, endowing outstanding hemocompatibility including low hemolysis, anticoagulation, and acceptable inflammatory response. The proof-of-concept hydrogel aortic valve displayed a low transvalvular pressure gradient of 14–24 mmHg, which efficiently regulates the flow direction and regurgitation and, more importantly, endures a cyclic pressure of ∼80 mmHg for at least 1.8 × 105 cycles yet maintaining a stable transvalvular pressure gradient without any damage to the configuration and performance. It is believed that the engineered hydrogel cardiac valves pave a significant way toward addressing the complications of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2022) studied Valvular heart diseases. RAFT-3D printed hydrogel bioprosthetic valves was evaluated on Transvalvular pressure gradient and durability. A proof-of-concept 3D-printed hydrogel aortic valve displayed a low transvalvular pressure gradient of 14–24 mmHg and endured a cyclic pressure of ~80 mmHg for at least 180,000 cycles.
Synapse has enriched 10 related papers. Consider them for comparative context: